Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer

This study aimed to investigate the cost-effectiveness, budget impact (BI), and impact of uncertainty of future developments concerning whole-genome sequencing (WGS) as a clinical diagnostic test compared with standard of care (SoC) in patients with locally advanced and metastatic non –small cell lung cancer.

Source: Value in Health - August 13, 2022 Category: International Medicine & Public Health Authors: Martijn J.H.G. Simons, Carin A. Uyl-de Groot, Valesca P. Ret èl, Joanne M. Mankor, Bram L.T. Ramaekers, Manuela A. Joore, Wim H. van Harten Tags: Economic Evaluation Source Type: research